Kura Oncology is a clinical-stage biopharmaceutical company focused on developing precision medicines for cancer treatment. The company's pipeline includes ziftomenib, tipifarnib, and KO-2806, targeting specific signaling pathways and drivers of cancer to improve patient outcomes. Kura emphasizes personalized medicine approaches and innovative research in solid tumors and blood cancers.
Kura Oncology is seeking a Director of Commercial Analytics and Performance Reporting to join their team, focused on the discovery and development of precision medicines. This role will lead a team in leveraging data to drive analytical insights that inform business questions, build robust reporting frameworks, and collaborate with cross-functional partners. The ideal candidate is a data-driven leader with a strong focus on integrity and grit.
Kura Oncology is a clinical-stage biopharmaceutical company focused on developing precision medicines for cancer treatment. The company's pipeline includes ziftomenib, tipifarnib, and KO-2806, targeting specific signaling pathways and drivers of cancer to improve patient outcomes. Kura emphasizes personalized medicine approaches and innovative research in solid tumors and blood cancers.
Kalkomey Enterprises, LLC